BlackRock Fund Advisors - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 85 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$71,844,000
+22.8%
3,900,323
+26.4%
0.01%
+8.3%
Q3 2016$58,523,000
+141.5%
3,085,037
+105.3%
0.01%
+140.0%
Q2 2016$24,229,000
+43.9%
1,503,059
+7.1%
0.01%
+25.0%
Q1 2016$16,835,000
-13.7%
1,402,948
+2.3%
0.00%
-20.0%
Q4 2015$19,517,000
+13.0%
1,371,557
-7.2%
0.01%
+25.0%
Q3 2015$17,278,000
-29.8%
1,478,032
+5.5%
0.00%
-33.3%
Q2 2015$24,621,000
+100.6%
1,400,491
+70.7%
0.01%
+100.0%
Q1 2015$12,273,000
+36.1%
820,374
+5.7%
0.00%
+50.0%
Q4 2014$9,015,000
+240.3%
776,444
+241.4%
0.00%
+100.0%
Q3 2014$2,649,000227,4180.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders